Since 2001, Integral Molecular's mission has been to develop and apply innovative technologies that advance therapeutic discovery against difficult protein targets, including viral proteins. Deep expertise in virology is at our core. We’ve developed technologies that have enabled hundreds of companies worldwide working in vaccine research and drug discovery. Our technologies have been published in over 500 papers and patents, including articles in Cell, Science, and Nature.